Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention

Stroke

Volumn 43, Issue 6, 2012, Pages 1532-1536

  Soo, Yannie O Y ^a   Siu, Deyond Y W ^a   Abrigo, Jill ^a   Yu, Simon ^a   Ng, Nick ^a   Ahuja, Anil T ^a   Wong, Lawrence K S ^a   Leung, Thomas W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cerebral microbleeds; endovascular intervention; hemorrhage; stenting; stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; ANGIOPLASTY; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; EXTRACRANIAL STENTING; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMAGE ANALYSIS; INTRACRANIAL STENTING; ISCHEMIC HEART DISEASE; LARGE ARTERY ATHEROSCLEROSIS; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOKING; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ASPIRIN; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TICLOPIDINE;

EID: 84861588236     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.626853     Document Type: Article

References (33)

1. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted mr images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20:637-642.
2. Chen YF, Chang YY, Liu JS, Lui CC, Kao YF, Lan MY. Association between cerebral microbleeds and prior primary intracerebral hemorrhage in ischemic stroke patients. Clin Neurol Neurosurg. 2008;110:988-991.
3. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007;130:1988-2003.
4. Fan YH, Mok VC, Lam WW, Hui AC, Wong KS. Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts. J Neurol. 2004;251:537-541.
5. Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology. 2006;66:165-171.
6. Sun J, Soo YO, Lam WW, Wong KS, Zeng JS, Fan YH. Different distribution patterns of cerebral microbleeds in acute ischemic stroke patients with and without hypertension. Eur Neurol. 2009;62:298-303.
7. van den Boom R, Bornebroek M, Behloul F, van den Berg-Huysmans AA, Haan J, van Buchem MA. Microbleeds in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neurology. 2005;64:1288-1289.
8. Fan YH, Zhang L, Lam WW, Mok VC, Wong KS. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke. 2003;34:2459-2462.
9. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35:1415-1420.
10. Jeon SB, Kang DW, Cho AH, Lee EM, Choi CG, Kwon SU, et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage. J Neurol. 2007;254:508-512.
11. Naka H, Nomura E, Takahashi T, Wakabayashi S, Mimori Y, Kajikawa H, et al. Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke types. AJNR Am J Neuroradiol. 2006;27:830-835.
12. Soo YO, Yang SR, Lam WW, Wong A, Fan YH, Leung HH, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol. 2008;255:1679-1686.
13. Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam scan study. Arch Neurol. 2009;66: 714-720.
14. Morrish W, Grahovac S, Douen A, Cheung G, Hu W, Farb R, et al. Intracranial hemorrhage after stenting and angioplasty of extracranial carotid stenosis. AJNR Am J Neuroradiol. 2000;21:1911-1916.
15. Adhiyaman V, Alexander S. Cerebral hyperperfusion syndrome following carotid endarterectomy. QJM. 2007;100:239-244.
16. Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CL, et al. Improving interrater agreement about brain microbleeds: development of the Brain Observer Microbleed Scale (BOMBS). Stroke. 2009;40: 94-99.
17. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22:711-720.
18. Gregoire SM, Jager HR, Yousry TA, Kallis C, Brown MM, Werring DJ. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry. 2010;81:679-684.
19. Wong KS, Chan YL, Liu JY, Gao S, Lam WW. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology. 2003;60:511-513.
20. Wong KS, Mok V, Lam WW, Kay R, Tang A, Chan YL, et al. Aspirinassociated intracerebral hemorrhage: clinical and radiologic features. Neurology. 2000;54:2298-2301.
21. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, et al. Bleeding Risk Analysis in Stroke Imaging Before Thrombolysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007;38:2738-2744.
22. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
23. Nielsen MY, Sillesen HH, Jorgensen LG, Schroeder TV. The haemodynamic effect of carotid endarterectomy. Eur J Vasc Endovasc Surg. 2002;24:53-58.
24. Buhk JH, Cepek L, Knauth M. Hyperacute intracerebral hemorrhage complicating carotid stenting should be distinguished from hyperperfusion syndrome. AJNR Am J Neuroradiol. 2006;27:1508-1513.
25. Vanninen R, Koivisto K, Tulla H, Manninen H, Partanen K. Hemodynamic effects of carotid endarterectomy by magnetic resonance flow quantification. Stroke. 1995;26:84-89.
26. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
27. McCabe DJ, Brown MM, Clifton A. Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke. 1999;30:2483-2486.
28. Chamorro A, Vila N, Obach V, Macho J, Blasco J. A case of cerebral hemorrhage early after carotid stenting. Stroke. 2000;31:792-793.
29. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial collaborators. N Engl J Med. 1998;339:1415-1425.
30. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113: 555-563.
31. Kastrup A, Groschel K, Ringer TM, Redecker C, Cordesmeyer R, Witte OW, et al. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke. 2008; 39:2385-2387.
32. Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, et al. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol. 2008;7:494-499.
33. Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, et al. Cilostazol for Prevention of Secondary Stroke (CSPS 2): an aspirincontrolled, double-blind, randomised non-inferiority trial. Lancet Neurol. 2010;9:959-968.